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Inherited paternal HLA antigens from the semi-allogeneic fetus may trigger maternal 
immune responses during pregnancy, leading to the production of child-specific HLA 
antibodies. The prevalence of these HLA antibodies increases with the number of 
successful pregnancies. In the present study, we investigated the effect of a single prior 
miscarriage on HLA antibody formation during a subsequent successful pregnancy. 
Women with a successful pregnancy with one or more prior miscarriages (n = 229) and 
women with a successful pregnancy without a prior miscarriage (n =  58), and their 
children were HLA typed. HLA antibody analyses were performed in these women to 
identify whether HLA antibodies were formed against mismatched HLA class-I antigens 
of the last child. The percentage of immunogenic antigens was significantly lower after a 
single successful pregnancy that was preceded by a single miscarriage (n = 18 women) 
compared to a successful pregnancy that was preceded by a first successful pregnancy 
(n =  62 women). Thus, our data suggest that a previous miscarriage has a different 
impact on child-specific HLA antibody formation during a subsequent successful 
pregnancy than a previous successful pregnancy. The lower immunogenicity in these 
women cannot be explained by reduced numbers of immunogenic B-cell and T-cell 
epitopes. In conclusion, our observations indicate that increasing gravidity is not related 
to an increased prevalence of HLA antibodies in a single successful pregnancy that was 
preceded by a single prior miscarriage.
Keywords: allo-sensitization, hla antibodies, pregnancy, miscarriage, Pirche-ii
Abbreviations: IPA, inherited paternal HLA antigens; MFI, mean fluorescence intensity; PIRCHE-II, Predicted Indirectly 
ReCognizable HLA Epitopes presented by HLA class-II.
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inTrODUcTiOn
A successful pregnancy requires an optimal interplay between 
the maternal immune system and the semi-allogeneic fetus. 
Breakdown of the maternal immune tolerance may result in 
fetal rejection. Thus, the maternal tolerance toward the fetus 
has to be maintained both locally at the fetal-maternal interface 
and systemically, since bidirectional trafficking of cells and 
soluble HLA between the mother and the fetus takes place 
(1–3). As  early as  4  weeks of gestation, semi-allogeneic fetal 
DNA can be  detected in the maternal circulation (2) and the 
presence of this fetal microchimerism can persist for decades 
after delivery (4).
Inherited paternal HLA antigens (IPA) of fetal origin are 
able to prime maternal immune responses at the fetal-maternal 
interface as well as in the maternal circulation (5, 6). These 
immune responses may lead to the production of child-specific 
HLA antibodies (7–9). The maternal production child-specific 
HLA antibodies of the IgG isotype requires interaction between 
activated B-cells and primed T-helper cells. First, B-cell activa-
tion occurs upon antigenic uptake of IPA by the B-cell receptor 
(10). Subsequently, upon T-cell recognition of degraded IPA 
presented on HLA class-II molecules, T-helper cells provide co-
stimulation via CD40–CD40L interaction and secrete cytokines 
(10, 11). These signals drive proliferation and differentiation of 
naive B cells into memory cells and plasma cells and induce IgM 
to IgG isotype switching (10, 11). Thus, the maternal production 
of child-specific IgG HLA antibodies requires the activation of 
B cells by T-helper cells where both B cells and T-helper cells 
respond to the same antigen, a phenomenon called linked rec-
ognition (12).
Despite abundant allogeneic fetal contact, only 10–40% of 
the mothers develop child-specific HLA antibodies (8, 9). The 
exact mechanism behind HLA antibody formation is currently 
unclear. Increasing gravidity (8, 13) and the fetal and maternal 
HLA phenotype combination (14) may be important determi-
nants in the immunogenicity toward IPA. We previously showed 
that HLA antibody formation during a successful pregnancy 
without prior miscarriages is related to the number of predicted 
HLA-derived T-helper epitopes as determined by the PIRCHE-II 
model (Predicted Indirectly ReCognizable HLA Epitopes) (15). 
This model identifies the number of mismatched HLA-derived 
peptides that can be presented by HLA class-II molecules, desig-
nated as PIRCHE-II (16).
HLA antibodies play an important role in organ transplanta-
tion; the presence of pre-transplantation donor-specific HLA 
antibodies is associated with antibody-mediated rejection and 
an impaired graft survival (17–20). Therefore, more insight into 
the immunogenicity of mismatched HLA after pregnancy may 
have has implications in the transplantation field. In contrast to 
transplantation, the effect of IPA-specific HLA antibodies on the 
fetus is presumably rather harmless, as the prevalence of IPA-
specific HLA antibodies is relatively high in normal pregnancies. 
However, both beneficial and harmful effects of HLA antibodies 
on pregnancy outcome have been described, indicating that the 
role of IPA-specific HLA antibodies on pregnancy outcome is 
debatable (21). Most of these studies focused on HLA antibody 
formation in (recurrent) miscarriage(s), whereas studies about 
the effect of a prior miscarriage on HLA antibody formation dur-
ing a subsequent successful pregnancy are limited. In the present 
study, we investigate for the first time the effect of a single previ-
ous miscarriage on HLA antibody formation during a subsequent 
first successful pregnancy.
MaTerials anD MeThODs
Population and sample collection
We included in this study 301 mothers who gave birth between 
September 2009 and April 2011 at the University Hospital Basel, 
Switzerland. All women included had either their first full-term 
pregnancy or gave birth to children from the same partner before. 
Fully HLA class-I matched mother–child pairs (n  =  3) were 
excluded from the analyses. In some mother–child pairs, the child 
was homozygous for a HLA class-I IPA for which the mother 
was heterozygous (n =  8). These mother–child pairs were also 
excluded from analyses, as these HLA class-I IPA was identical 
to the mother and thus not immunogenic. From all participat-
ing women, blood transfusions and previous miscarriages were 
documented. Three women had previous blood transfusions, and 
these mother–child pairs were excluded from further analysis. 
From the remaining 287 mother–child pairs, a total of 58 women 
had one or more prior miscarriages. These women with one of 
more prior miscarriages were used to study the effect of a prior 
miscarriage on HLA antibody formation during a subsequent 
successful pregnancy.
After obtaining informed consent from all the participating 
women, blood samples were taken from the mother 1–4  days 
after delivery. Cord blood of the child was sampled directly after 
delivery. HLA antibody analysis was performed on the maternal 
blood samples, and HLA typing was performed on blood samples 
that were obtained from both the mother and the cord blood. 
This study was approved by the local ethics committee (EKBB; 
reference number 23/09).
hla Typing
High-resolution HLA typing was performed on maternal blood 
samples and cord blood samples using either sequence-based 
typing (www.histogenetics.com) or SSO DNA typing (LABType 
HD; One Lambda). Identification of mismatched IPA was based 
on two-field resolution HLA typing of both mother and child.
hla antibody analysis
Maternal post-delivery blood samples were analyzed for the 
presence of HLA antibodies using single HLA class I-antigen 
beads according to the instructions of the manufacturer (iBeads 
Lot 1; One Lambda) as described previously (9). For the analyses 
presented in this paper, we consider mean fluorescence intensity 
>1,000 as positive. Mismatched HLA class-I IPA against which 
the mother had developed HLA-specific antibodies were classi-
fied as immunogenic HLA, whereas mismatched HLA class-I IPA 
against which the mother had not developed HLA-specific anti-
bodies were classified as non-immunogenic HLA. The percentage 
of immunogenic antigens was calculated for individual groups by 
TaBle 1 | Population characteristics.
Without prior miscarriage, n (%) With prior miscarriage(s), n (%)
1 prior miscarriage 2 prior miscarriages ≥3 prior miscarriages
First full-term pregnancy 154 (53.7) 18 (6.3) 7 (2.4) 4 (1.4)
Second full-term pregnancy 65 (22.6) 15 (5.2) 5 (1.7) 2 (0.7)
Third or more full-term pregnancy 10 (3.5) 4 (1.4) 2 (0.7) 1 (0.3)
TaBle 2 | number of mismatched inherited paternal hla antigens (iPa) 
per locus; n (% immunogenic iPa per locus).
hla-a hla-B hla-c
Pregnancies without prior miscarriage 234 (16%) 259 (17%) 245 (6%)
Pregnancies with prior miscarriage(s) 40 (20%) 54 (20%) 48 (15%)
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dividing the number of immunogenic HLA by the total number 
of HLA class-I IPA mismatches multiplied by 100%.
identification of hla class-i-Derived 
Pirche-ii
The numbers of HLA class-I derived epitopes from the child 
presented by maternal HLA class-II molecules, PIRCHE-II, 
were determined as described previously (15). Briefly, for all 
mismatched HLA-A, HLA-B, and HLA-C antigens of the child, 
we used the netMHCIIpan-3.0 algorithm to predict how mis-
matched HLA-derived peptide may align in the binding groove 
of maternal HLA-DRB1 [algorithm available via http://www.
cbs.dtu.dk/services/NetMHCIIpan-3.0/ (22)]. Subsequently, 
the binding affinity of this peptide to maternal HLA-DRB1 was 
predicted by the algorithm, considering binding affinities with an 
IC50 of <1,000 nM as relevant HLA-DRB1 binders. HLA-DRB1 
binders were designated as a PIRCHE-II when the predicted 
binders differed at least one amino acid with the maternal HLA 
amino acid sequence. Only unique child-specific epitope-HLA 
complexes were counted as a PIRCHE-II. The PIRCHE algorithm 
is available via http://www.pirche.org.
hlaMatchmaker
HLAMatchmaker version 2.1 was used to determine the number 
of HLAMatchmaker eplets for all mismatched HLA class-I mole-
cules of the child. Eplets that were present in HLA of the child and 
absent in the mother’s HLA-A, HLA-B, HLA-C, and HLA-DRB1 
locus were counted as mismatched eplets. The HLAMatchmaker 
software is available via http://www.epitopes.net (23).
statistical analysis
We used the GraphPad Prism software version 6.02 (GraphPad 
Software, Inc., La Jolla, CA, USA) and the SPSS Statistics soft-
ware version 20 (IBM SPSS Software) for the statistical analyses. 
Pearson’s chi-square tests were used to analyze differences in 
percentage of immunogenic antigens between different groups. 
Mann–Whitney U tests were used to analyze differences in the 
number of mismatched eplets and PIRCHE-II between differ-
ent groups. p-values <0.05 were assumed to indicate statistical 
significance.
resUlTs
Population characteristics
Table 1 summarizes the characteristics of the study population. 
Of all 287 women, the majority of the women (79.8%) did not 
have any prior miscarriage. A total of 58 women had one or more 
prior miscarriages. The majority of these women with a prior 
miscarriage had a single prior miscarriage. In all 287 women, 738 
HLA-class I IPA mismatches were identified. Table 2 summarizes 
the number of mismatched IPA for pregnancies with and without 
prior miscarriage(s) and the percentage of immunogenic HLA 
per locus. The percentage of immunogenic IPA between these 
groups did not significantly differ (p = 0.72, p = 0.64, and p = 0.08 
for HLA-A, HLA-B, and HLA-C, respectively, in Pearson’s chi-
square tests with Yates’ correction).
First Pregnancy and First Miscarriage 
have a Different impact on hla antibody 
Formation during a subsequent 
successful Pregnancy
Multiple successful pregnancies and prior miscarriages may 
have a differential effect on HLA immunization during a 
subsequent successful pregnancy. To investigate the effect of a 
first pregnancy and a first miscarriage on HLA antibody forma-
tion during a subsequent successful pregnancy, we compared 
secundigravidae without a prior miscarriage (i.e., these women 
had two successful pregnancies without a prior miscarriage; 
n = 65 women) with secundigravidae with a prior miscarriage 
(i.e., these women had a single successful pregnancy that was 
preceded by a single miscarriage; n = 18 women) (Figure 1). The 
secundigravidae without a prior miscarriage group had a total 
of 162 HLA class I mismatched IPA, whereas the secundigravi-
dae with a prior miscarriage had 44 HLA class I-mismatched 
IPA. The percentage of immunogenic antigens was higher for 
secundigravidae without a prior miscarriage (21%) compared 
to secundigravidae with a prior miscarriage (2.3%) (Figure 1; 
p =  0.003). For the secundigravidae with a prior miscarriage, 
only a single HLA was immunogenic (HLA-C*01:02), while 
the other 43 mismatched HLA were non-immunogenic. When 
using a lower fluorescence intensity cutoff (>500), the percent-
age of immunogenic antigens for secundigravidae with a prior 
miscarriage increased marginally (4.5%). These observations 
indicate that the HLA immunogenicity is significantly lower 
during a subsequent successful pregnancy in women who 
experienced a prior miscarriage compared to women who had 
a prior successful pregnancy. The percentage of immunogenic 
FigUre 1 | The effect of first pregnancy and first miscarriage on 
subsequent successful pregnancy. The percentage of immunogenic 
antigens is higher for secundigravidae without a prior miscarriage (black bar) 
than secundigravidae with a prior miscarriage (gray bar). The dotted line 
represents the percentage of immunogenic antigens for primigravidae 
(women with a single successful full-term pregnancy; 14.6%). For each 
group, n represents the number of mismatched antigens. The p value is 
derived from Pearson’s chi-square test.
FigUre 2 | The effect of the number of prior miscarriage on hla 
sensitization during a subsequent successful pregnancy. HLA 
sensitization in women with a single successful pregnancy that was 
preceded by a single prior miscarriage was compared with HLA 
sensitization in women with a single successful pregnancy that was 
preceded by multiple prior miscarriages. The percentage of immunogenic 
antigens is higher for women with multiple a prior miscarriages (dark gray 
bar) than for women with a single prior miscarriage (light gray bar). For each 
group, n represents the number of mismatched antigens. The p value is 
derived from Pearson’s chi-square test.
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antigens in the secundigravidae with a prior miscarriage group 
was also lower than the percentage of immunogenic antigens 
in the primigravidae group (i.e., these women had a single 
successful pregnancy without a history of prior miscarriages) 
(dotted line in Figure 1; 14.6%; primigravidae versus secundi-
gravidae with a prior miscarriage: p =  0.02), indicating that 
the immunization pattern observed in secundigravidae with a 
prior miscarriage is not similar to the immunization pattern 
observed in primigravidae.
Next, we investigated the effect of the number of prior mis-
carriages on HLA sensitization during a subsequent successful 
pregnancy. We compared the percentage of immunogenic 
antigens between women with a single successful pregnancy that 
was preceded by a single prior miscarriage (i.e., secundigravidae 
with a prior miscarriage) and women with a single successful 
pregnancy that was preceded by multiple prior miscarriages 
(Figure  2). For women with multiple prior miscarriages, the 
percentage of immunogenic HLA was higher (23.3%) compared 
to women with a single prior miscarriage (2.3%) (Figure  2; 
p =  0.004), indicating that the number of prior miscarriages 
may influence HLA sensitization during a subsequent successful 
pregnancy.
We previously showed that the probability of HLA antibody 
formation increases with the number of PIRCHE-II in successful 
pregnancies without a prior miscarriage (15). Thus, we showed 
that in these pregnancies, including secundigravidae without a 
prior miscarriage, a higher number of PIRCHE-II was related 
to a higher percentage of immunogenic antigens. Therefore, one 
could hypothesize that the single immunogenic HLA-C*01:02 in 
the secundigravidae with prior miscarriage group has a higher 
number of PIRCHE-II compared to the other non-immunogenic 
HLA. To investigate this aspect in the secundigravidae with a prior 
miscarriage group, the PIRCHE-II numbers for the mismatched 
antigens were divided into quintiles (i.e., five equal groups) 
(Figure 3). For each of these quintiles, we plotted the percentage 
of immunogenic antigens, and we investigated in which quintile 
the single immunogenic HLA-C*01:02 of secundigravidae 
with a prior miscarriage was present. The single immunogenic 
HLA-C*01:02 is not an outlier, as it was present in the central 
quintile (12–16 PIRCHE-II). This observation indicates that the 
lower percentage of immunogenic HLA in the secundigravidae 
with a prior miscarriage group cannot be explained by having 
an increased or a reduced number of PIRCHE-II compared to 
non-immunogenic HLA.
The lower immunogenicity in 
secundigravidae with a Prior 
Miscarriage is likely not Due to 
lower numbers of immunogenic B cell 
and T-helper cell epitopes
The ability to develop HLA antibodies against child-specific HLA 
mismatches is determined by allo-epitopes that are present on 
mismatched HLA. The HLAMatchmaker algorithm identifies 
FigUre 4 | comparison of the number of immunogenic factors 
between secundigravidae without a prior miscarriage and 
secundigravidae with a prior miscarriage. Non-immunogenic HLA of 
secundigravidae with a prior miscarriage contains a similar number of 
mismatched eplets (a) and PIRCHE-II (B) compared to non-immunogenic 
HLA of secundigravidae without a prior miscarriage. For the secundigravidae 
with a prior miscarriage group, the single immunogenic HLA is depicted as a 
dot. The reported p-values are derived from Mann–Whitney U tests. The 
boxes extend from the 25th to 75th percentiles, and the middle line 
represents the median. The whiskers are drawn from the lowest to the 
highest PIRCHE-II value.
FigUre 3 | The single immunogenic hla in the secundigravidae with 
a prior miscarriage group has a median number of Pirche-ii. The 
number of PIRCHE-II was divided into quintiles (0–4 PIRCHE-II, 5–11 
PIRCHE-II, 12–16 PIRCHE-II, 17–21 PIRCHE-II, and 22+ PIRCHE-II). For 
each individual quintile, the percentage of immunogenic antigens was 
plotted. All HLA mismatches present in the 0–4 PIRCHE-II, 5–11 PIRCHE-II, 
17–21 PIRCHE-II, and the 22+ PIRCHE-II quintiles were non-immunogenic, 
resulting in 0% immunogenic antigens. The single immunogenic 
HLA-C*01:02 is present in the 12–16 PIRCHE-II quintile, whereas the other 
HLA mismatches present in this PIRCHE-II quintile were non-immunogenic, 
resulting in 11.1% immunogenic antigens. For each group, n represents the 
number of mismatched antigens.
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the number of antibody-accessible allo-epitopes (eplets) on mis-
matched HLA that are not present on self-HLA. To investigate 
whether the lower immunogenicity in secundigravidae with 
a prior miscarriage is due to a lower number of immunogenic 
B-cell epitopes in this population, we calculated the number of 
mismatched eplets for secundigravidae with a prior miscarriage 
and for secundigravidae without a prior miscarriage (Figure 4A). 
Since only a single HLA of the secundigravidae with a prior 
miscarriage is immunogenic, analyses were performed on the 
non-immunogenic HLA groups of both populations. The num-
ber of eplets did not differ between non-immunogenic HLA of 
secundigravidae with a prior miscarriage and non-immunogenic 
HLA of secundigravidae without a prior miscarriage (p = 0.51). 
When analyzing the number of PIRCHE-II (T-helper cell 
epitopes) in both groups (Figure 4B), the number of PIRCHE-II 
was similar for non-immunogenic HLA of secundigravidae 
with a prior miscarriage compared to non-immunogenic HLA 
of secundigravidae without a prior miscarriage (p = 0.54). Thus 
both the eplet and PIRCHE-II numbers are comparable between 
secundigravidae with a miscarriage and secundigravidae with-
out a miscarriage, indicating that the number of immunogenic 
factors (i.e., B-cell and T-helper cell epitopes) is not altered in 
secundigravidae with a prior miscarriage.
DiscUssiOn
Maternal immune responses can be formed against IPA of the 
fetus during pregnancy, leading to IPA-specific antibodies and 
T cells (5, 7). Despite the clinical relevance of HLA-specific 
antibodies in transplantation outcome, the clinical relevance 
of paternal HLA-specific antibodies in pregnancy outcome 
is currently unclear (21). The present study was initiated to 
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investigate the effect of a first pregnancy and a first miscarriage 
on HLA antibody formation during a subsequent first successful 
pregnancy.
In our cohort of 287 mother–child pairs, we investigated 
HLA immunization against mismatched IPA of the most recent 
child in secundigravidae with or without a single prior miscar-
riage. The percentage of immunogenic HLA was significantly 
lower in secundigravidae with a prior miscarriage compared 
to secundigravidae without a prior miscarriage. Several studies 
have shown that the prevalence of HLA antibodies increases 
with the number of successful pregnancies (9, 13). Our data 
show that the relation between increasing gravidity and the 
prevalence of HLA antibody formation is absent in secundi-
gravidae with a prior miscarriage, indicating that a previous 
miscarriage behaves differently when compared to a previous 
successful pregnancy.
Our results suggest that a prior miscarriage has a different 
immunological impact on a subsequent successful pregnancy 
than a prior successful pregnancy. The lower immunogenicity 
observed in secundigravidae with a prior miscarriage cannot 
be explained by altered numbers of mismatched eplets and 
PIRCHE-II (Figure  4). Alternatively, the lower percentage 
of immunogenic antigens among secundigravidae with prior 
miscarriage in our population may result from tolerizing 
effects of a first short allogeneic interaction during the prior 
miscarriage. These tolerizing effects may be caused by fetal 
microchimerism, as the increased occurrence and long-term 
persistence of fetal microchimerism in the maternal system 
after or during fetal loss has been described previously (24, 
25). Alternatively, the low percentage of immunogenic antigens 
among secundigravidae with a single prior miscarriage might 
also be explained by natural selection of a particular HLA geno-
type during a subsequent pregnancy. The chance of inheriting 
an alternative paternal haplotype during a subsequent success-
ful pregnancy compared to the previous miscarriage is 50%. 
However, a previous miscarriage may further stimulate HLA 
genotype diversity by putting additive selective pressure on a 
subsequent pregnancy. Either directly or via modulating the 
maternal immune system, the HLA genotype of the miscarried 
fetus may discriminate against that particular HLA genotype 
during or shortly after conception (26). If this hypothesis is 
correct, a previous miscarried fetus facilitates the selection of 
the HLA genotype of a subsequent child. Such a selection may 
be achieved via a maternal immune response directed against 
the HLA genotype that is similar to the HLA genotype of the 
miscarriage itself, resulting in either selective abortion of the 
fetus or via a female alloimmune response against certain HLA 
genotypes present in seminal fluid, as seminal plasma contains 
soluble HLA (27) and spermatozoa also express both HLA 
class-I and class-II (28). However, currently no data are avail-
able to support such a natural selection of a particular HLA 
genotype. To challenge this hypothesis, the HLA typing of the 
current child should be compared with the HLA typing of the 
previous miscarried fetus. HLA typing of the miscarried fetus 
is not available for the current cohort and is in general hard 
to obtain. Alternatively, inclusion of paternal HLA typing may 
provide a better insight in this mechanism.
The duration of maternal exposure to allo-epitopes is sig-
nificantly shorter during a miscarriage compared to a full-term 
pregnancy. Therefore, one might argue that alloimmunization 
is negligible in pregnancies that end in a miscarriage and that 
the alloimmunization pattern of secundigravidae with a prior 
miscarriage is more comparable to the alloimmunization pattern 
of primigravidae. In this study, we showed that the percentage 
of immunogenic antigens for secundigravidae with a prior 
miscarriage was also lower than the percentage of immunogenic 
antigens observed for primigravidae (Figure 1), demonstrating 
that the immunization pattern in secundigravidae with a prior 
miscarriage differs from the immunization pattern that was 
observed in primigravidae. Thus, despite a shorter duration of 
maternal allo-exposure during pregnancy loss, the effect of a 
prior miscarriage on a subsequent pregnancy cannot be neglected 
in terms of HLA antibody formation.
Although our investigation on the differential effect of a first 
pregnancy and a first miscarriage on a subsequent successful preg-
nancy are unprecedented, our observation might be supported by 
previous reports. For example, Triulzi et al. showed that women 
with a single pregnancy that ended in a miscarriage had a dimin-
ished HLA alloimmunization compared to women with a single 
pregnancy that ended in a successful delivery (13). Furthermore, 
Masson et al. reported that the HLA immunization incidence was 
diminished in women with a single successful pregnancy that was 
preceded by one or more miscarriages compared to women with 
a single successful pregnancy that was not preceded by one or 
more miscarriages (29). However, the latter study did not take the 
number of prior miscarriages into account. In our population, we 
observed that women with a single successful pregnancy that was 
preceded by two or more miscarriages had a higher percentage 
of immunogenic antigens than women with a single successful 
pregnancy that was preceded by a single miscarriage (Figure 2). 
This observation indicates that the number of prior miscarriages 
may have impact on HLA sensitization during a subsequent suc-
cessful pregnancy.
The probability of HLA antibody formation increases with the 
number of PIRCHE-II in pregnancies that were not preceded by 
one or more miscarriages, including secundigravidae without a 
prior miscarriage (15). In our cohort of secundigravidae with a 
prior miscarriage, the single immunogenic HLA had a number of 
PIRCHE-II that was comparable to the other non-immunogenic 
HLA (Figure 4), indicating that the PIRCHE-II effect is absent in 
pregnancies that were preceded by miscarriages.
Our study has limited details about the miscarried fetus itself, 
as the paternity, HLA typing, and cause of the miscarriage were 
not documented. Furthermore, the miscarriages in our cohort 
were self-reported. Since a majority of the miscarriages are 
unnoticed (30), it may well be that the number of prior miscar-
riages is underestimated. Therefore, also in the secundigravidae 
without prior miscarriage group and in the primigravidae group 
some women might have previous miscarriages, which may 
led to underestimation of immunization toward IPA in normal 
pregnancies. Moreover, serum samples for HLA antibody analy-
sis after the miscarriage are lacking for our cohort. These latter 
serum samples may answer the question whether the mother had 
developed HLA antibodies against the miscarried fetus or not and 
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would provide more insight in the possible mechanisms behind 
our observations.
In summary, we showed that a previous miscarriage and a 
previous successful pregnancy have a different impact on HLA 
antibody formation during a subsequent successful pregnancy. 
In contrast to successful pregnancies, increasing gravidity is not 
related to increased child-specific HLA antibody formation in 
secundigravidae with a prior miscarriage. Further details about 
the miscarried fetus itself or paternal HLA typing will be required 
to explain the observed different impact of a previous miscarriage 
and a previous successful pregnancy on child-specific HLA anti-
body formation during a subsequent successful pregnancy. These 
data may help to understand the mechanism of child-specific 
HLA antibody formation during a successful pregnancy that was 
preceded by a miscarriage and therefore will have implications in 
the transplantation field.
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